financetom
Business
financetom
/
Business
/
Insmed Insider Sold Shares Worth $708,681, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insmed Insider Sold Shares Worth $708,681, According to a Recent SEC Filing
May 26, 2025 9:02 AM

04:34 PM EDT, 05/15/2025 (MT Newswires) -- Sara Bonstein, Chief Financial Officer, on May 13, 2025, sold 10,504 shares in Insmed ( INSM ) for $708,681. Following the Form 4 filing with the SEC, Bonstein has control over a total of 108,359 common shares of the company, with 108,359 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1104506/000162828025025980/xslF345X05/wk-form4_1747340945.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lifeway Foods Insider Sold Shares Worth $542,554, According to a Recent SEC Filing
Lifeway Foods Insider Sold Shares Worth $542,554, According to a Recent SEC Filing
May 21, 2024
05:51 PM EDT, 05/21/2024 (MT Newswires) -- Julie Smolyansky, 10% Owner, Director, CEO, President and Secretary, on May 17, 2024, sold 30,105 shares in Lifeway Foods ( LWAY ) for $542,554. Following the Form 4 filing with the SEC, Smolyansky has control over a total of 2,611,269 shares of the company, with 2,084,417 shares held directly and 526,852 controlled indirectly....
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship
Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship
May 21, 2024
05:51 PM EDT, 05/21/2024 (MT Newswires) -- Nanobiotix ( NBTX ) said Tuesday it has aligned with Johnson & Johnson's ( JNJ ) Janssen Pharmaceutica at their Joint Strategy Committee to transfer the global sponsorship of the phase 3 head and neck cancer trial of NBTXR3 in preparation for potential regulatory submission in the event of positive trial results. The...
Haemonetics Insider Sold Shares Worth $254,443, According to a Recent SEC Filing
Haemonetics Insider Sold Shares Worth $254,443, According to a Recent SEC Filing
May 21, 2024
05:51 PM EDT, 05/21/2024 (MT Newswires) -- Michelle L Basil, Executive Vice President and General Counsel, on May 17, 2024, sold 2,677 shares in Haemonetics ( HAE ) for $254,443. Following the Form 4 filing with the SEC, Basil has control over a total of 31,257 shares of the company, with 31,257 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/313143/000112760224016164/xslF345X03/form4.xml Price: 88.00,...
Paycom Software Insider Sold Shares Worth $701,128, According to a Recent SEC Filing
Paycom Software Insider Sold Shares Worth $701,128, According to a Recent SEC Filing
May 21, 2024
05:52 PM EDT, 05/21/2024 (MT Newswires) -- Chad R. Richison, 10% Owner, Director, Co-CEO, President and Chairman, on May 20, 2024, sold 3,900 shares in Paycom Software ( PAYC ) for $701,128. Following the Form 4 filing with the SEC, Richison has control over a total of 6,776,241 shares of the company, with 3,090,008 shares held directly and 3,686,233 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved